Endep and Leflunomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Endep (amitriptyline hydrochloride) and Leflunomide (leflunomide). Common drug interactions include arthralgia among females and blindness unilateral among males.

The phase IV clinical study analyzes what interactions people have when they take Endep and Leflunomide. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Endep?

Endep has active ingredients of amitriptyline hydrochloride. It is often used in fibromyalgia. eHealthMe is studying from 1,302 Endep users. Check the latest studies of Endep.

What is Leflunomide?

Leflunomide has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 82,105 Leflunomide users. Check the latest studies of Leflunomide.



On Jul, 07, 2026

13 people who take Endep and Leflunomide together, and have interactions are studied.

Endep and Leflunomide drug interactions.

What are the common drug interactions of Endep and Leflunomide, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Diarrhoea
  3. Hypertension (high blood pressure)
  4. Urticaria (rash of round, red welts on the skin that itch intensely)
  5. Apathy
  6. Asthenia (weakness)
  7. Burning feet syndrome (burning sensation in the sole of the foot)
  8. Confusional state
  9. Conjunctivitis (pink eye)
  10. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)

male:

  1. Blindness unilateral
  2. Body mass index increased
  3. Thyroid disorder (thyroid diseases)
  4. Weight decreased
  5. Diarrhoea
  6. Fatigue (feeling of tiredness)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Pain in extremity
  10. Psychiatric symptom

What are the common drug interactions of Endep and Leflunomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Apathy
  2. Arthralgia (joint pain)
  3. Asthenia (weakness)
  4. Burning feet syndrome (burning sensation in the sole of the foot)
  5. Confusional state
  6. Conjunctivitis (pink eye)
  7. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  8. Diarrhoea
  9. Haematuria (presence of blood in urine)
  10. Hypertension (high blood pressure)

50-59:

  1. Blindness unilateral
  2. Body mass index increased
  3. Diarrhoea
  4. Fatigue (feeling of tiredness)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Pain in extremity
  8. Psychiatric symptom
  9. Pyrexia (fever)
  10. Renal impairment (severely reduced kidney function)

60+:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Oral pain
  4. Pain in extremity
  5. Pneumonia cytomegaloviral (cmv pneumonia is caused by a member of a group of herpes-type viruses)
  6. Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
  7. Poor quality sleep
  8. Red cell distribution width increased
  9. Renal impairment (severely reduced kidney function)
  10. Vision blurred

What are the existing conditions these people have? *

  1. Cryoglobulinaemia (blood contains large amounts of cryoglobulins - proteins): 4 people, 30.77%
  2. Insomnia (sleeplessness): 2 people, 15.38%
  3. Depression: 2 people, 15.38%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 15.38%
  5. Osteoporosis (bones weak and more likely to break): 2 people, 15.38%
  6. Vitamin B12 Deficiency: 1 person, 7.69%
  7. Asthma: 1 person, 7.69%
  8. Atrophy (wasting away of a part of the body): 1 person, 7.69%
  9. Constipation: 1 person, 7.69%
  10. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Endep and Leflunomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Endep and Leflunomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Endep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Leflunomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Endep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Leflunomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride and leflunomide (the active ingredients of Endep and Leflunomide, respectively), and Endep and Leflunomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: